This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Ahmed MM , Sheldon D , Fruitwala MA , Venkatasubbarao K , Lee FY , Gupta S , Wood C , Mohiuddin M , Strodel WE
Downregulation of PAR-4, a pro-apoptotic gene, in pancreatic tumors harboring K-ras mutation
International Journal of Cancer. 2008 Jan;122(1) :63-70
AbstractOncogenic ras is known to inhibit cell death and growth inhibitory genes and activate prosurvival genes. Proapoptotic gene PAR-4, has been found to be downregulated by oncogenic ras. Since pancreatic tumors harbor a high incidence of K-ras point mutations, we hypothesized that oncogenic K-ras might influence the function and expression of PAR-4. PAR-4 expression levels were analyzed in 4 established pancreatic tumor cell lines, 10 normal pancreatic tissues, 44 frozen tumor tissues and 25 paraffin-embedded pancreatic adenocarcinoma samples by Real Time RT-PCR, Western blot analysis and immunohistochemistry. K-ras mutational status was analyzed by allele-specific oligonucleotide-hybridization. Expression levels of PAR-4 were correlated with the K-ras mutational status and clinical characteristics. Further, modulation of endogenous PAR-4 was tested by transiently expressing oncogenic ras in a wild-type K-ras pancreatic cancer cell line, BxPC-3. Three cell lines with K-ras mu!
NotesAhmed, Mansoor M. Sheldon, David Fruitwala, Mushtaq A. Venkatasubbarao, Kolaparthi Lee, Fun Y. Gupta, Seema Wood, Craig Mohiuddin, Mohammed Strodel, William E. WILEY-LISS